Open AccessPasireotide treatment in Cushing's disease: A single tertiary center's experience
Author(s) -
SERDAR ŞAHİN,
GULAR KARİMOVA,
ŞEYDA GÜL ÖZCAN,
EMRE DURCAN,
HANDE MEFKURE ÖZKAYA,
PINAR KADIOĞLU
Publication year - 2022
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.55730/1300-0144.5335
Subject(s) - medicine , pasireotide , adverse effect , cushing's disease , gastroenterology , acromegaly , endocrinology , disease , hormone , growth hormone
Patients who were followed up for CD and treated with pasireotide between 2014-2020 at Cerrahpaşa Medical Faculty, were evaluated retrospectively. The efficacy and adverse effects of pasireotide were evaluated in this study.